Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04136314 · ClinicalTrials.gov registry record · NA
Impact of Decision-Framing in Psoriasis
A NA study, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT04136314 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 90 participants.
The verdict
NCT04136314, a NA study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
Rationale: Shared decision-making models between clinicians and patients are critical to improving healthcare delivery and adherence to medication. One type of model, decision framing, is rarely studied in medicine. Decision framing is the way that a choice is worded. In a clinical context, patient choices can be worded positively, or "gain-framed", to explain the benefits of a therapy or negatively, or "loss-framed", to explain the risks of not taking a therapy. Previous literature suggests that decision-framing can significantly influence patients' decision-making regarding their healthcare. However, a critical gap exists in understanding how decision framing affects psoriasis patients' preferences for therapies. Objective: Determine whether loss-framed messages lead to greater therapy acceptance as compared to gain-framed messages among adults with psoriasis. Study population: 90 adults with psoriasis will be enrolled from USC ambulatory clinics and the general public. Intervention: Subjects will be exposed to gain-framed or loss-framed messages regarding psoriasis therapies. Specifically, gain-framed messages will explain the expected benefits of taking the psoriasis therapy and loss-framed messages will explain the potential risks of not taking the psoriasis therapy. Study Methodology: Cross-sectional single-intervention survey.
Interventions
- BEHAVIORAL Decision-Framed Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2019-10-21 |
| Est. Completion | 2020-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04136314
The ClinicalTrials.gov registry entry for NCT04136314 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Decision-Framed Survey is the first listed.
NCT04136314 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04136314 about?
NCT04136314 is a clinical study titled "Impact of Decision-Framing in Psoriasis". Rationale: Shared decision-making models between clinicians and patients are critical to improving healthcare delivery and adherence to medication. One type of model, decision framing, is rarely studied in medicine. Decision framing is the way that a choice is worded. In a clinical context, patient...
What is the current status of trial NCT04136314?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2019-10-21. Estimated completion is 2020-01-31.
What interventions are being tested in trial NCT04136314?
The interventions under investigation include: Decision-Framed Survey (BEHAVIORAL).
Who is sponsoring clinical trial NCT04136314?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.